SENNE PHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
SENNE PHARMA
Largest movements
- Stocks and contracts -€39,452
down €39,452 (-13.6%), from €290,169 to €250,717
- Tangible fixed assets -€35,029
down €35,029 (-18.1%), from €193,334 to €158,305
of which Land and buildings: -€39,530
- Cash +€24,597
up €24,597 (+23.1%), from €106,629 to €131,227
mainly Depreciation (+€41,913) and Stocks and contracts (+€39,452)
- Receivables within one year +€9,320
up €9,320 (+14.5%), from €64,251 to €73,570
of which Trade receivables: +€4,829
- Debts after one year -€22,344
down €22,344 (-9.5%), from €234,178 to €211,835
of which Financial debts: -€22,344
- Reserves +€17,024
up €17,024 (+12.7%), from €134,139 to €151,164
of which Distributable reserves: +€17,024
- Other debts -€17,011
down €17,011 (-58.0%), from €29,328 to €12,317
- Trade debts -€15,478
down €15,478 (-9.6%), from €160,473 to €144,995
- Staff costs -€50,225
down €50,225 (-52.1%), from €96,476 to €46,251
- Gross operating margin -€40,054
down €40,054 (-24.1%), from €166,293 to €126,239
- Taxes +€5,612
up €5,612 (+136%), from €4,131 to €9,743
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €658,514 | €617,578 | -€40,936 | -6.2% |
| Fixed assets | 21/28 | €193,469 | €158,440 | -€35,029 | -18.1% |
| Tangible fixed assets | 22/27 | €193,334 | €158,305 | -€35,029 | -18.1% |
| Land and buildings | 22 | €189,726 | €150,197 | -€39,530 | -20.8% |
| Plant, machinery and equipment | 23 | €1,706 | €6,677 | +€4,971 | +291% |
| Furniture and vehicles | 24 | €1,901 | €1,432 | -€469 | -24.7% |
| Financial fixed assets | 28 | €135 | €135 | = | 0.0% |
| Current assets | 29/58 | €465,045 | €459,138 | -€5,907 | -1.3% |
| Stocks and contracts in progress | 3 | €290,169 | €250,717 | -€39,452 | -13.6% |
| Stocks | 30/36 | €290,169 | €250,717 | -€39,452 | -13.6% |
| Amounts receivable within one year | 40/41 | €64,251 | €73,570 | +€9,320 | +14.5% |
| Trade receivables | 40 | €4,465 | €9,295 | +€4,829 | +108% |
| Other amounts receivable | 41 | €59,785 | €64,276 | +€4,491 | +7.5% |
| Cash at bank and in hand | 54/58 | €106,629 | €131,227 | +€24,597 | +23.1% |
| Deferred charges and accrued income | 490/1 | €3,997 | €3,624 | -€373 | -9.3% |
| Total equity and liabilities | 10/49 | €658,514 | €617,578 | -€40,936 | -6.2% |
| Equity | 10/15 | €180,597 | €197,622 | +€17,024 | +9.4% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €134,139 | €151,164 | +€17,024 | +12.7% |
| Non-distributable reserves | 130/1 | €1,860 | €1,860 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,860 | €1,860 | = | 0.0% |
| Tax-exempt reserves | 132 | €1,157 | €1,157 | = | 0.0% |
| Distributable reserves | 133 | €131,122 | €148,147 | +€17,024 | +13.0% |
| Profit (loss) carried forward | 14 | €27,858 | €27,858 | = | 0.0% |
| Amounts payable | 17/49 | €477,917 | €419,957 | -€57,960 | -12.1% |
| Amounts payable after more than one year | 17 | €234,178 | €211,835 | -€22,344 | -9.5% |
| Financial debts | 170/4 | €184,705 | €162,362 | -€22,344 | -12.1% |
| Other amounts payable | 178/9 | €49,473 | €49,473 | = | 0.0% |
| Amounts payable within one year | 42/48 | €236,782 | €204,619 | -€32,162 | -13.6% |
| Current portion of amounts payable after more than one year | 42 | €21,989 | €22,344 | +€355 | +1.6% |
| Trade debts | 44 | €160,473 | €144,995 | -€15,478 | -9.6% |
| Suppliers | 440/4 | €160,473 | €144,995 | -€15,478 | -9.6% |
| Taxes, remuneration and social security | 45 | €24,991 | €24,964 | -€28 | -0.1% |
| Taxes | 450/3 | €2,521 | €2,634 | +€113 | +4.5% |
| Remuneration and social security | 454/9 | €22,470 | €22,330 | -€140 | -0.6% |
| Other amounts payable | 47/48 | €29,328 | €12,317 | -€17,011 | -58.0% |
| Accrued charges and deferred income | 492/3 | €6,957 | €3,503 | -€3,454 | -49.7% |
| Remuneration, social security and pensions | 62 | €96,476 | €46,251 | -€50,225 | -52.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €42,602 | €41,913 | -€688 | -1.6% |
| Other operating charges | 640/8 | €3,156 | €2,237 | -€918 | -29.1% |
| Non-recurring operating charges | 66A | - | €441 | +€441 | |
| Gross operating margin | 9900 | €166,293 | €126,239 | -€40,054 | -24.1% |
| Operating profit (loss) | 9901 | €24,060 | €35,396 | +€11,336 | +47.1% |
| Financial income | 75/76B | €241 | €1,558 | +€1,317 | +547% |
| Recurring financial income | 75 | €241 | €38 | -€203 | -84.2% |
| Non-recurring financial income | 76B | - | €1,520 | +€1,520 | |
| Financial charges | 65/66B | €10,926 | €10,187 | -€739 | -6.8% |
| Recurring financial charges | 65 | €10,926 | €10,187 | -€739 | -6.8% |
| Profit (loss) for the period before taxes | 9903 | €13,375 | €26,767 | +€13,392 | +100% |
| Income taxes | 67/77 | €4,131 | €9,743 | +€5,612 | +136% |
| Profit (loss) for the period | 9904 | €9,244 | €17,024 | +€7,780 | +84.2% |
| Profit (loss) for the period to be appropriated | 9905 | €9,244 | €17,024 | +€7,780 | +84.2% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 19 October 2026 via checked.be.